3-n-butylphthalide has been researched along with Nervous System Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, L; Han, W; Sun, GB; Xiao, HY; Yang, SX | 1 |
| Chen, Q; Tan, L; Tu, E; Wang, Y | 1 |
| Chen, X; Li, Z; Lu, J; Ma, L; Wang, R; Wu, C; Xu, Z; Ye, X; Zhao, Y | 1 |
| Bai, JH; Chen, XQ; He, Q; Liu, H; Lu, W; Qiu, K | 1 |
| Du, R; Shi, ZB; Teng, JF; Wang, Y; Zhao, XY | 1 |
| Abdoulaye, IA; Guo, YJ | 1 |
| Chan, WM; Dong, J; Huang, Y; Qi, W; Wai, MS; Wang, C; Wang, YX; Yew, DT; Yu, WH; Zhang, L; Zhao, F | 1 |
2 review(s) available for 3-n-butylphthalide and Nervous System Diseases
| Article | Year |
|---|---|
Application and prospects of butylphthalide for the treatment of neurologic diseases.
Topics: Animals; Benzofurans; Humans; Nervous System Diseases; Neuroprotective Agents; Oxidative Stress | 2019 |
A Review of Recent Advances in Neuroprotective Potential of 3-N-Butylphthalide and Its Derivatives.
Topics: Apium; Apoptosis; Benzofurans; Humans; Inflammation; Nervous System Diseases; Neuroprotective Agents; Oxidative Stress; Plant Extracts | 2016 |
1 trial(s) available for 3-n-butylphthalide and Nervous System Diseases
| Article | Year |
|---|---|
Clinical study of Butylphthalide combined with Xue Shuan Tong on serum inflammatory factors and prognosis effect of patients with cerebral infarction.
Topics: Aged; Aged, 80 and over; Benzofurans; Calcitonin Gene-Related Peptide; Carotid Arteries; Carotid Intima-Media Thickness; Cerebral Infarction; Drugs, Chinese Herbal; Female; Humans; Inflammation; Interleukin-2; Male; Middle Aged; Nervous System Diseases; Plaque, Atherosclerotic; Prognosis | 2015 |
4 other study(ies) available for 3-n-butylphthalide and Nervous System Diseases
| Article | Year |
|---|---|
[Research progress on pharmacology of butylphthalide and its derivatives].
Topics: Benzofurans; Humans; Nervous System Diseases; Neuroprotective Agents; Oxidative Stress | 2022 |
Dl-3-n-Butylphthalide promotes neovascularization and neurological recovery in a rat model of intracerebral hemorrhage.
Topics: Animals; Benzofurans; Brain; Cerebral Hemorrhage; Disease Models, Animal; Male; Nervous System Diseases; Rats, Sprague-Dawley; Stroke; Vascular Endothelial Growth Factor A | 2020 |
dl-3-n-butylphthalide for alleviation of neurological deficit after combined extracranial-intracranial revascularization for moyamoya disease: a propensity score-matched analysis.
Topics: Adult; Benzofurans; Cerebral Revascularization; Cohort Studies; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Moyamoya Disease; Nervous System Diseases; Neuroprotective Agents; Pilot Projects; Postoperative Complications; Propensity Score; Prospective Studies | 2019 |
DL-3-n-Butylphthalide, an anti-oxidant agent, prevents neurological deficits and cerebral injury following stroke per functional analysis, magnetic resonance imaging and histological assessment.
Topics: Analysis of Variance; Animals; Antioxidants; Benzofurans; Brain Infarction; Brain Injuries; Cerebral Cortex; Disease Models, Animal; Infarction, Middle Cerebral Artery; Magnetic Resonance Imaging; Male; Nervous System Diseases; Neurologic Examination; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazolium Salts | 2012 |